Colorectal Cancer
Showing NaN - NaN of 84
Cardiovascular Toxicity: Comprehensive Myocardial and Vascular
Recruiting
- Cardiovascular Diseases
- +7 more
- Cardiovascular magnetic resonance with stress perfusion
- +4 more
-
London, United KingdomSt Bartholomews Hospital
Sep 15, 2023
COlorectal BReath Analysis (COBRA2)
Recruiting
- Colorectal Cancer
- Breath test
-
London, United Kingdom
- +4 more
Apr 25, 2023
Seismofit® asEstimate of VO2 Peak in Hepato-pancreato-biliary,
Recruiting
- Hepato-Biliary Carcinoma in Situ Nos
- +4 more
- Non-Interventional
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Apr 24, 2023
Colorectal Cancer, Polyp of Colon, Adenoma Colon Trial in Worldwide (CADDIE)
Not yet recruiting
- Colorectal Cancer
- +2 more
- CADDIE
-
Berlin, Germany
- +3 more
Feb 19, 2023
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +
Recruiting
- Colorectal Cancer
- +4 more
- NUC-3373 + leucovorin
- +8 more
-
Boston, Massachusetts
- +9 more
Jan 23, 2023
NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- GDC-6036
- +6 more
-
Duarte, California
- +68 more
Jan 10, 2023
Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)
Active, not recruiting
- Melanoma
- +7 more
- Autogene cevumeran
- Atezolizumab
-
Scottsdale, Arizona
- +36 more
Dec 22, 2022
Colorectal Cancer Trial in Worldwide (favezelimab/pembrolizumab, regorafenib, TAS-102)
Active, not recruiting
- Colorectal Cancer
- favezelimab/pembrolizumab
- +2 more
-
Washington, District of Columbia
- +151 more
Oct 12, 2022
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- Pembrolizumab
- Lenvatinib
-
Duarte, California
- +87 more
Aug 19, 2022
Colorectal Cancer Trial in Worldwide (Pembrolizumab, Pembrolizumab/Quavonlimab, Pembrolizumab/Favezelimab)
Recruiting
- Colorectal Cancer
- Pembrolizumab
- +4 more
-
Orange City, Florida
- +54 more
Aug 17, 2022
Urinary Bladder Tumors, Colorectal Cancer, NSCLC Trial in Worldwide (AZD8853, Zirconium-89 crefmirlimab berdoxam)
Recruiting
- Urinary Bladder Neoplasms
- +2 more
- AZD8853
- Zirconium-89 crefmirlimab berdoxam
-
New Haven, Connecticut
- +14 more
Aug 8, 2022
Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan
Not yet recruiting
- Endometrial Cancer
- +4 more
- Datopotamab deruxtecan (Dato-DXd)
- +8 more
-
Los Angeles, California
- +52 more
Aug 3, 2022
Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)
Recruiting
- Ovarian Cancer
- +10 more
-
West Hollywood, California
- +27 more
Jun 27, 2022
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)
Recruiting
- Colorectal Cancer
- +3 more
- Nivolumab
- +3 more
-
Birmingham, Alabama
- +101 more
Jun 13, 2022
Sarcopenic Male Colorectal Cancer Patients
Recruiting
- Colorectal Cancer
- +4 more
-
London, United KingdomLondon North West University Healthcare NHS Trust
May 4, 2022
Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus
Terminated
- Advanced Gastrointestinal (GI) Malignancies
- +3 more
- ADI-PEG 20 plus modified FOLFOX6
-
San Francisco, California
- +34 more
Apr 18, 2022
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Recruiting
- Breast Cancer
- +10 more
-
Hamilton, Ontario, Canada
- +6 more
Apr 21, 2022
The Colorectal Breath Analysis (COBRA) Study
Active, not recruiting
- Colorectal Cancer
- +2 more
- Breath sample
-
London, United Kingdom
- +7 more
Apr 20, 2022
Colorectal Cancer Trial in Canada, Puerto Rico, United States (celecoxib, 5-fluorouracil, )
Computer Aided Diagnosis of Colorectal Polyps
Completed
- Colonic Polyp
- Colorectal Cancer
- Endobrain, Computer Aided Diagnosis (CAD)
-
London, United KingdomKing's College Hospital
Jan 17, 2022
Colorectal Cancer, Chemo-induced Peripheral Neuropathy Trial in Worldwide (Calmangafodipir (2 µmol/kg), Calmangafodipir (5
Terminated
- Colorectal Cancer
- Chemotherapy-induced Peripheral Neuropathy
- Calmangafodipir (2 µmol/kg)
- +2 more
-
Fresno, California
- +97 more
Nov 19, 2021